D. E. Shaw & Co., Inc. Adma Biologics, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 6,824,517 shares of ADMA stock, worth $132 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,824,517
Previous 5,381,718
26.81%
Holding current value
$132 Million
Previous $35.5 Million
114.81%
% of portfolio
0.08%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$362 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$281 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$255 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$173 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$156 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.81B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...